Eva Comperat, MD, Hospital Tenon, discusses the treatment strategy for patients with neuroendocrine tumors (NETs).
Eva Comperat, MD
Advertisement
Articles by Eva Comperat, MD
Advertisement
Latest Updated Articles
Dr. Comperat on the Treatment Strategy for Neuroendocrine TumorsOctober 6th 2017
Advertisement
Advertisement
Trending on OncLive
1
Savolitinib Plus Osimertinib NDA Submitted to FDA for MET-Driven, EGFR-Mutated NSCLC After EGFR TKI
2
Calculating the Real Cost of False Positive Findings in Cancer Screening
3
FDA Grants Priority Review to Elinzanetant for Endocrine Therapy–Associated Vasomotor Symptoms in HR+ Breast Cancer
4
Cilta-Cel Shows Long-Term Treatment-Free Remissions in Lenalidomide-Refractory Myeloma
5